Transforming growth factor beta-mediated micromechanics modulates disease progression in primary myelofibrosis
Teodorescu P. et al, (2020), JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 24, 11100 - 11110
Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis
Tomuleasa C. et al, (2018), Journal of Cellular Physiology, 233, 422 - 433
PARP inhibitors in acute myeloid leukaemia therapy: How a synthetic lethality approach can be a valid therapeutic alternative
Gafencu GA. et al, (2017), Medical Hypotheses, 104, 30 - 34
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
Tomuleasa C. et al, (2016), International Journal of Nanomedicine, 641 - 641